Is India immune to coronavirus?

India coronavirus covid-19 growth

11 March 2020
| By Oksana Patron |
image
image
expand image

Although the coronavirus is not expected to stop India’s structural growth, it will impact global growth in at least the first half of 2020 and therefore India’s growth, India Avenue Investment Management said.

Investors should be reminded that even though India did not have significant links to the global supply chain (exports are only 11% of gross domestic product), it benefited when global growth was strong given comparative advantages in exports of refined petrochemicals/oils, gems/precious stones, textiles, electronics, pharmaceuticals and automobiles.

“As we have always articulated to investors, India is a market where you should build exposure during dire times as the structural story will outlast any cyclical events. It’s a matter of portfolio construction and investment horizon,” India Avenue said in a note.

“When it comes to satellite investments like investing in India, investors typically tend to sell during adversity and buy during euphoria.”

However, the virus still had potential to become the key risk for India, given it would make itself a home amongst India’s significant population of 1.3 billion and its potential for it to spread quickly, without appropriate healthcare systems and medication for all.

According to India Avenue, while it was hard at this point to estimate the potential damage to markets, there were some positives such as:

  • US$475 billion ($730.3 billion) of forex reserves to defend the currency if required 
  • A substantial fall in the oil price which will reduce inflationary pressures in India (India imports over 80% of its oil usage)
  • Central Bank potential to cut cash rates from 5.15%
  • Fiscal stimulus likely to be forth coming
  • Potential to replace China in certain aspects of the global supply chain, given most are now seeking diversity of supply. Foreign direct investment in India has increased significantly over the last 12 months (US$175 billion vs US$87 billion previous year)

“We think it is inevitable that India starts its recovery in in the 2H21 i.e. Sept 2020 onwards. It is not very often that you can identify an investment where you can buy quality growth stocks at P/E’s in the teens and cyclical growth for single digit P/E’s in a market like India. We are re-aligning our fund to go overweight in the both these segments,” the manager said.

Read more about:

AUTHOR

Recommended for you

 
sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

 

MARKET INSIGHTS

PETER JOHNSTON- AIOFP

Well done Keith and Neil, these Canberra Bureaucrats need to be stopped. ...

15 hours ago
JOHN GILLIES

WHEN I RETIRED A LOT OF GUY'S WERE STILL PRACTICING FORMS OF COLD CALLING. There nothing wrong with it as a way of estab...

1 day 14 hours ago
JOHN GILLIES

I thought you joined a dealer to be protected and have a better version of regulation explained, BUT The dealers themsel...

1 day 15 hours ago

ASIC has cancelled the AFS licence of a Sydney wealth firm, the fifth Sydney firm to see a cancellation since the start of the year....

1 week 1 day ago

A former financial adviser has been banned by ASIC from providing financial services for inappropriate advice, among multiple breaches....

3 weeks 2 days ago

ASIC has suspended the AFS licence of a Melbourne fund manager responsible for six managed investment schemes....

2 weeks 2 days ago

TOP PERFORMING FUNDS

ACS FIXED INT - AUSTRALIA/GLOBAL BOND